Apple Loses Bid to Overturn $634 Million Masimo Patent Verdict
A court refused to throw out the $634M judgment against Apple in the Masimo patent case, keeping major legal risk on the books.
Apple just took another hit in its long-running patent war with medical device maker Masimo. A court denied Apple's attempt to overturn a $634 million verdict, meaning that massive judgment stays firmly in place — and the legal headache isn't going away anytime soon.
This ruling matters if you're watching Apple's balance sheet. $634 million isn't pocket change even for a company sitting on hundreds of billions in cash, but the bigger concern is precedent. If Apple can't shake this verdict, it signals that its health-sensor tech — the kind baked into the Apple Watch — carries real intellectual property liability.
Read more Progress Software Buys Domo's AI and Data Platform Unit →
Meanwhile, a separate trade-secret dispute tied to the same battle is now heading to appeal, which means this saga has another chapter. Two fronts of litigation running simultaneously is exactly the kind of overhang that makes institutional investors uncomfortable, even if retail traders tend to shrug it off.
The Masimo case has already forced Apple to briefly pull Apple Watch models from US shelves in a prior skirmish over pulse oximetry patents. That episode showed the market that this isn't just a paper threat — regulators and courts are willing to act. Watch how Apple navigates the appeal phase; it could set the tone for how aggressively the company defends its wearables ecosystem going forward.
Continue reading at Yahoo
